Literature DB >> 9561954

An outcome study of Missouri's CSTAR alcohol and drug abuse programs.

R C Evenson1, P R Binner, D W Cho, W W Schicht, J M Topolski.   

Abstract

The Comprehensive Substance Abuse Treatment and Rehabilitation (CSTAR) program is described, and a study of its services is presented. The CSTAR program is a community program with wrap-around services and intensive case management. Eleven domains typically affected by substance abuse were measured, plus satisfaction with treatment services. A retrospective study of 280 clients at 10 facilities was done, and results analyzed separately by General Programs. Women with Children programs, and Adolescent programs. A small sample of clients who were early in their treatment was re-interviewed 90 days later. Data were also examined according to length of stay in the program. Results were consistently positive, and increased with length of time in the program.

Entities:  

Mesh:

Year:  1998        PMID: 9561954     DOI: 10.1016/s0740-5472(97)00009-3

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  4 in total

Review 1.  The development and implementation of case management for substance use disorders in North America and Europe.

Authors:  Wouter Vanderplasschen; Richard C Rapp; Judith R Wolf; Eric Broekaert
Journal:  Psychiatr Serv       Date:  2004-08       Impact factor: 3.084

Review 2.  Effectiveness of different models of case management for substance-abusing populations.

Authors:  Wouter Vanderplasschen; Judith Wolf; Richard C Rapp; Eric Broekaert
Journal:  J Psychoactive Drugs       Date:  2007-03

Review 3.  Maternal substance use and integrated treatment programs for women with substance abuse issues and their children: a meta-analysis.

Authors:  Karen Milligan; Alison Niccols; Wendy Sword; Lehana Thabane; Joanna Henderson; Ainsley Smith; Jennifer Liu
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-09-01

4.  "New Choices" for women with addictions: perceptions of program participants.

Authors:  Wendy Sword; Alison Niccols; Aimei Fan
Journal:  BMC Public Health       Date:  2004-04-15       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.